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ABSTRACT
The transcription program that is responsible for the pluri-
potency of human ESCs (hESCs) is believed to be comain-
tained by exogenous ﬁbroblast growth factor-2 (FGF-2),
which activates FGF receptors (FGFRs) and stimulates the
mitogen-activated protein kinase (MAPK) pathway. How-
ever, the same pathway is stimulated by insulin receptors,
insulin-like growth factor 1 receptors, and epidermal
growth factor receptors. This mechanism is further compli-
cated by intracrine FGF signals. Thus, the molecular mech-
anisms by which FGF-2 promotes the undifferentiated
growth of hESCs are unclear. Here we show that, in undif-
ferentiated hESCs, exogenous FGF-2 stimulated the expres-
sion of stem cell genes while suppressing cell death and
apoptosis genes. Inhibition of autocrine FGF signaling
caused upregulation of differentiation-related genes and
downregulation of stem cell genes. Thus, exogenous FGF-2
reinforced the pluripotency maintenance program of intra-
crine FGF-2 signaling. Consistent with this hypothesis,
expression of endogenous FGF-2 decreased during hESC
differentiation and FGF-2 knockdown-induced hESC dif-
ferentiation. In addition, FGF-2 signaling via FGFR2 acti-
vated MAPK kinase/extracellular signal-regulated kinase
and AKT kinases, protected hESC from stress-induced cell
death, and increased hESC adhesion and cloning efﬁciency.
This stimulation of self-renewal, cell survival, and adhesion
by exogenous and endogenous FGF-2 may synergize to
maintain the undifferentiated growth of hESCs. STEM
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INTRODUCTION
Human ESCs (hESCs) are potential models of human devel-
opment and disease and an unlimited source of cell replace-
ment therapies. The crucial challenge for these applications is
to understand how to maintain and expand hESCs in an undif-
ferentiated state without acquiring genetic abnormalities. The
current optimized cell culture conditions that support long-
term undifferentiated growth of hESCs include the extrinsic
activities of several growth factors and a supporting feeder
cell layer. Feeder-free culture conditions are less supportive
for the unlimited undifferentiated culture of hESCs and
require feeder cell-conditioned medium or elevated concentra-
tions of growth factors. The most common growth factors
supplements for hESC culture media that promote self-
renewal are ﬁbroblast growth factor-2 (FGF-2) [1, 2], activin
A [3–5], transforming growth factor b1 (TGFb1) [6], and
Wnt1 and 3 [7–9]. Although the majority of these growth fac-
tors are not necessary for culture of hESCs with feeder cells
or feeder cell-conditioned media, FGF-2 is required. This
seems to be paradoxical because FGF-2 stimulates trophecto-
derm differentiation [10], the early stages of endodermal de-
velopment [11], differentiation of endoderm-derived pancre-
atic cells [12], and differentiation of mesoderm-derived
cardiovascular progenitors [13]. One possible explanation is
that FGF-2 has different effects on undifferentiated cells than
cells that are already committed to differentiate.
In undifferentiated hESCs FGF-2 likely promotes self-
renewal in several ways. It directly activates the mitogen-acti-
vated protein kinase (MAPK) pathway [1, 14], whereas indi-
rectly it acts on ﬁbroblast feeder cells to modulate TGFb1
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renewal [15, 16]. FGF-2 also induces the production of TGFb
and insulin-like growth factor-II (IGF-II) from hESC-derived
ﬁbroblast-like cells that deﬁne a self-renewal-supporting
hESC niche [17]. More recently, one study has suggested that
extrinsic FGF-2 signaling directly regulates NANOG promoter
activity [18]. Remarkably, although the activation of the
MAPK cascade by exogenous FGF-2 stimulates mouse ESC
proliferation [19], it does not stimulate hESC proliferation [1,
14]. There are at least two possible explanations for this dis-
parity in hESCs. First, the MAPK pathway may be predomi-
nantly activated by insulin receptors, insulin-like growth fac-
tor 1 receptors (IGF1Rs), and epidermal growth factor
receptors (EGFRs) [20] in hESCs, thus buffering the action of
exogenous FGF-2 on cell proliferation. Second, intracrine
FGF activities in hESCs may maintain high levels of MAPK
activation such that proliferation is not further enhanced by
extrinsic FGF signals. In support of the second hypothesis,
mouse ESCs were suggested to have an innate program for
self-renewal that does not require extrinsic signals [21]. The
excess of exogenous growth factors may also have receptor-
independent mechanisms that negatively regulate pathways
that direct pluripotent cell differentiation. Consistent with
these proposed mechanisms, FGF-2 is highly expressed in
various somatic cell types, where it has established intrinsic
function in the regulation of cell proliferation, differentiation,
and survival [22, 23].
In this study, we suggested that intrinsic FGF-2 signaling
maintained the undifferentiated growth and survival of hESCs.
In contrast, exogenous FGF-2 had partially overlapping func-
tions in the maintenance of hESC undifferentiated growth and
survival, but in addition, stimulated hESC adhesion that indi-
rectly contributed to the maintenance of hESCs pluripotency.
Thus, we propose that the maintenance of hESC self-renewal
by intracrine FGF-2 is enhanced by extrinsic FGF-2 signals.
MATERIALS AND METHODS
Culture of hESCs
Karyotypically normal CCTL12 (46, XX) and CCTL14 (46, XX)
hESC lines [24] were routinely maintained in Dulbecco’s modi-
ﬁed Eagle medium (DMEM)/F12 supplemented with 15% (vol/
vol) knockout serum replacement, L-glutamine, MEM nonessen-
tial amino acids, 0.5% (vol/vol) penicillin-streptomycin, 5 ng/ml
FGF-2 (all media components from Invitrogen, Carlsbad, CA,
http://www.invitrogen.com), and b-2 mercaptoethanol (Sigma-
Aldrich, St. Louis, http://www.sigmaaldrich.com) on mitotically
inactivated embryonic ﬁbroblasts from the CF 1 mouse strain.
Passage numbers 21-69 (CCTL12) and 22-57 (CCTL14) were
used for all experiments.
DNA Array Analysis
hESCs were cultured in standard FGF-2 (5 ng/ml)-supplemented
medium or in medium without FGF-2 but supplemented with 20
lM SU5402 (Calbiochem, San Diego, http://www.emdbioscien-
ces.com) for 6 days. Control cells for both treatments were cul-
tured in medium without FGF-2. Two independent replicates
were hybridized to Agilent Human 1A v2 chips containing 60-
mer oligonucleotide probes covering transcripts for approximately
20,000 annotated human genes (Agilent Technologies, Palo Alto,
CA, http://www.agilent.com). Genes that were equally expressed
in both replicates were selected for further analysis. Functional
annotation of genes was performed according to the KEGG path-
ways using the FatiGOplus program [25].
Immunoblotting and Immunocytochemistry
For immunoblot analysis of FGF-2, hESCs lysates containing
equal amounts of total protein were mixed with 2  Laemmli
sample buffer, separated by SDS-PAGE, and electrotransferred
onto Hybond P membrane (Amersham Pharmacia Biotech, Buck-
inghamshire, U.K., http://www.gelifesciences.com). Membranes
were incubated with mouse FB-8 monoclonal antibody to FGF-2
(Sigma-Aldrich). Mouse monoclonal antibody to a-tubulin
(ExBio, Prague, Czech Republic, http://www.exbio.cz) was used
to normalize loading. Membranes were incubated with appropri-
ate horseradish peroxidase-conjugated secondary antibodies, and
protein bands were visualized using the chemiluminescence
detection reagent ECLþ Plus (Amersham).
For in situ detection, hESCs growing on mouse feeder layers
were ﬁxed either with 95% ethanol and 1% acetic acid, or 4%
paraformaldehyde, blocked with 5% normal goat serum or bovine
serum albumin (BSA), and incubated with primary antibodies
diluted in blocking solution. Primary antibodies included rabbit
polyclonal antibody to FGF-2 (Sigma-Aldrich), mouse monoclo-
nal antibody to Oct4 (Santa Cruz Biotechnology, Santa Cruz, CA,
http://www.scbt.com), rabbit polyclonal antibody to Nanog (Santa
Cruz Biotechnology), and rabbit polyclonal antibody to Ki-67
(Santa Cruz Biotechnology). Unbound antibody was removed,
and cells were incubated with the appropriate secondary antibod-
ies conjugated to peroxidase (Sigma-Aldrich), Alexa Fluor 488
(Invitrogen), and/or Alexa Fluor 594 (Invitrogen). Cell nuclei
were stained with 40,6-diamidino-2-phenylindole (DAPI) and
mounted in Mowiol (Polysciences, Warrington, PA, http://
www.polysciences.com) containing 1,4-diazobicyclo-[2.2.2.]-oc-
tane to prevent fading. Microscopic analysis was performed using
an Olympus FluoView 500 laser scanning microscope (Olympus,
Tokyo, http://www.olympus-global.com).
Reverse Transcription-Polymerase Chain Reaction
and Quantitative Real-Time Reverse Transcription-
Polymerase Chain Reaction Analysis
Reverse transcription-polymerase chain reaction (RT-PCR) for
FGF-2 and real-time RT-PCR for FGF receptors (FGFRs) were
performed as previously described [1, 16]. Supporting information
Table 1 lists the primes and probes used for RT-PCR and real-
time RT-PCR. Samples from sorted SSEA3-positive cells were
kindly provided by P. W. Andrews, University of Shefﬁeld, Shef-
ﬁeld, U.K. Samples of the independent hESC line HS237 were
kindly provided by O. Hovatta, Karolinska Institutet, Huddinge,
Sweden.
FGF-2 Binding Assay
Biotinylation of FGF-2 was performed using the EZ-Link Micro
NHS-PEO4-Biotinylation kit (Thermo Fisher Scientiﬁc, Bonn,
Germany, http://www.thermo.com) according to the manufac-
turer’s instructions. For the receptor-binding assay, hESCs were
cultured with or without FGF-2 for 5 days. The cells were rinsed
extensively and incubated on ice in DMEM/H/B (DMEM/F12,
15 mM HEPES, and 0.5% BSA) containing 10, 50, or 100 ng/ml
biotinylated FGF-2 for 30, 60, or 90 minutes. Control cells were
maintained in DMEM/H/B. The cells were rinsed three times
with DMEM/H/B, ﬁxed in 95% ethanol/1% acetic acid, and
quenched with 5% normal goat serum/1% BSA. This was fol-
lowed by incubation with streptavidin/ﬂuorescein isothiocyanate
(Vector Laboratories, Burlingame, CA, http://www.vectorlabs.-
com). Cells were rinsed, counterstained with DAPI, and mounted
in Mowiol containing 1,4-diazobicyclo-[2.2.2.]-octane. Fluores-
cence signal analysis was performed using an Olympus FluoView
500 laser scanning microscope (Olympus).
shRNA-Mediated Gene Silencing
The FGF-2 gene was knocked down using validated small hairpin
RNA (shRNA) oligonucleotides: 50-ACCGGATTCTGGAGTA-
TACTTATTCAAGA GATAAGTATACTCCAGAATCCTTTTTC-30
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CTTGAATAAGTATAC TCCAGAATC-30 (antisense) of FGF-2
mRNA (Ambion, Austin, TX, http://www.ambion.com) cloned
into the psiSTRIKE-Hygromycin vector (Promega, Madison, WI,
http://www.promega.com). Nonsilencing shRNA oligonucleotides
50-Accg cttgaaccgccagatctattcaagagatagatctggcggttcaagctttttc-30
(sense) and 50-tgcagaaaaagcttgaaccgccagatctatctctt gaatagatctgg-
cggttcaag-30 (antisense) [26] were cloned in to the same vector to
serve as a negative control. Low passage hESCs (passage 31) at
80% conﬂuency growing on hygromycin-resistant mouse feeder
cells (Millipore, Billerica, MA, http://www.millipore.com) were
transfected using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. Stable integration of the plasmid
encoding FGF-2 shRNA was selected using 75 lg/ml hygromycin
for 2-3 weeks. Resulting hESCs colonies were tested for the
presence of psiSTRIKE-Hygromycin vector by PCR (primers:
50-GCGATTAAGTTGGGTAAC-30;5 0-ACGCAATTAATGTGA-
GTTAG-30; resulting in a 620-bp fragment), replated onto normal
feeder cells, and expanded for further experiments. The knock-
down effect for FGF-2 was detected in hESC subclones by immu-
noblot analysis.
Phospho-Speciﬁc Protein Arrays and
Mitogen-Activated Protein Kinase Assay
The relative phosphorylation status of tyrosine kinase receptors
was assayed using the Human Phospho-Receptor Tyrosine Kinase
array (R&D Systems, Minneapolis, http://www.rndsystems.com)
according to the manufacturer’s instructions. The phosphorylation
of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) and
their substrate extracellular signal-regulated kinases (ERK1/2),
was determined by immunoblot analysis. Primary antibodies
included rabbit polyclonal antibody to phospho MEK1/2 (New
England Biolabs, Ipswich, MA, http://www.neb.com), rabbit poly-
clonal antibody to MEK1/2 (New England Biolabs), mouse
monoclonal antibody to phospho ERK1/2 (Santa Cruz Biotech-
nology), and rabbit polyclonal antibody to ERK1/2 (Santa Cruz
Biotechnology). After incubation with peroxidase-conjugated sec-
ondary antibodies (Sigma-Aldrich), protein bands were visualized
using the chemiluminescence detection reagent ECLþPlus
(Amersham Pharmacia Biotech). Determination of the relative
phosphorylation level of MAPKs including serine/threonine ki-
nases was performed using the Human Phospho-MAPK array kit
(R&D Systems) according to the manufacturer’s instructions.
Cell Death and Viability Assays
Detection of apoptotic hESCs after ionizing radiation and oxida-
tive stress was performed using the ApopTag Plus Fluorescein In
Situ Apoptosis detection kit (Millipore) according to the manufac-
turer’s instructions. The percentage of apoptotic cells was deter-
mined by ﬂuorescence microscopy with an Olympus FluoView
500 laser scanning microscope (Olympus). Samples of 1,000-
2,000 cells growing either in the presence or absence of 18-kDa
FGF-2 on 35-mm dishes (ibidi GmbH, Martinsried, Germany,
http://www.ibidi.de) were counted for each experimental group.
The cleavage of poly(ADP-ribose) polymerase-1 (PARP-1)
and lamin B in hESCs subjected to ionizing radiation and oxida-
tive stress was used to assess the activation of caspase-3 and apo-
ptotic disintegration of the nuclear envelope, respectively. The
cleavage products were detected by immunoblotting with the fol-
lowing primary antibodies: rabbit polyclonal antibody to PARP
(Santa Cruz Biotechnology) and goat polyclonal antibody to
lamin B (Santa Cruz Biotechnology). After incubation with per-
oxidase-conjugated secondary antibodies (Sigma-Aldrich), protein
bands were visualized using the chemiluminescence detection rea-
gent ECLþPlus (Amersham Pharmacia Biotech). Cell viability
and cell counts were determined using the ViCell XR (Immuno-
tech a.s., a Beckman Coulter Company, Prague, Czech Republic,
http://www.immunotech.cz).
Cloning Efﬁciency Assay
Human ESCs were FGF-2 starved for 6 hours, washed with PBS,
treated with TrypLE reagent (Invitrogen) for 3 minutes, and
gently dissociated to single cells by pipetting either in medium
with or without FGF-2 (50-100 ng/ml). Then, TrypLE reagent
was washed out by centrifugation, and single cell suspensions of
cells were preincubated in fresh medium with or without FGF-2
(50-100 ng/ml) for 1 hour. Dissociated cells were seeded at the
density of 1   10
4/cm
2 on 24-well feeder cell-coated plates and
cultured overnight in the same media with or without high con-
centrations of FGF-2. The following day, FGF-2-free and FGF-2-
high culture medium was replaced by a standard culture medium
supplemented with 5 ng/ml FGF-2. After 5 days of culture, when
hESCs formed colonies that were homogenous in size, the cells
were ﬁxed by 4% paraformaldehyde and stained with the Alka-
line Phosphatase Detection kit (Millipore). To determine the clon-
ing efﬁciency, each well of a 24-well plate was photographed,
and colony counting was performed using ImageJ software (Ras-
band WS, U.S. National Institutes of Health, Bethesda, MD,
http://rsbweb.nih.gov/ij/).
RESULTS
Gene Expression Analysis Highlights Importance of
Intrinsic FGF Signals in hESCs
Human ESCs express high levels of endogenous FGF-2 that
might signal in autocrine, paracrine, or intracrine ways. To
address the effects of intrinsic FGF-2 signaling on gene
expression, we blocked autocrine/paracrine FGF signaling
with the inhibitor of FGFR kinases SU5402 in cells that were
starved of exogenous FGF-2, and changes in the global gene
expression pattern were assessed using DNA microarrays. In
parallel controls, uninhibited hESCs maintained in medium
supplemented with or without FGF-2 were also analyzed
using DNA microarrays. In two independent experiments, we
observed characteristic gene expression changes; however, the
number and magnitude of the fold change of differentially
expressed genes were higher in cells exposed to SU5402. Spe-
ciﬁcally, SU5402-treated cells had 223 genes that were higher
(fold change of 1.4-9.8) and 198 genes that were lower (fold
change of 1.4-9.7) in SU5402-treated cells than FGF-2-starved
controls. On the other hand, only 30 genes were higher (fold
change of 1.4-2.8) and 96 genes lower (fold change of 1.4-
3.0) in FGF-2-treated cells than FGF-2-starved controls. Three
of the genes that were upregulated in SU5402-treated cells
were ANXA-1-4 (annexins 1-4) and KRT-8 and -18 (cytokera-
tins 8 and 18). The genes that were downregulated in
SU5402-treated cells include POU5F1 (OCT4), DNMT3B,
TERF1, and GAL. FGF-2-treated hESCs upregulated LEFTY-
1, CASP3, TIMP4, PVRL-3, HESX-1, and GAL genes and
downregulated of SLC16A3, TXNIP, SRC, and PTHR1. Lists
of genes that were regulated by exogenous FGF-2 or SU5402
exposure are shown in supporting information Table 2.
Our analysis of transcriptional responses of hESCs to
SU5402 or FGF-2 treatment was performed on selected tran-
scription factor networks and molecular and biochemical path-
ways. This functional clustering of differentially expressed
genes showed an involvement of FGF-2 signaling in cell ad-
hesion, adherens junctions, and transcriptional regulation of
genes involved in the self-renewal and differentiation of
hESCs. Intrinsic and extrinsic FGF signals had more signiﬁ-
cant effects on transcriptional regulators than other molecular
or biochemical pathways. Functional clustering of deregulated
genes is shown in Tables 1 and 2 and supporting information
Tables 3 and 4. Taken together, these results show that en-
dogenous autocrine/paracrine FGF signaling plays a crucial
role in maintenance of the undifferentiated growth of hESCs.
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Downregulated During Differentiation and
Correlates with Increased Binding Capacity
for Exogenous FGF-2
Next we wanted to determine whether the expression of en-
dogenous FGF-2 is restricted to undifferentiated hESCs. En-
dogenous FGF-2 is gradually downregulated during formation
and growth of embryoid bodies (EBs). Importantly, this
downregulation of FGF-2 is isoform selective. Undifferenti-
ated hESCs expressed nuclear high molecular mass (HMM:
22, 22.5, and 24 kDa) and cytoplasmic low molecular mass
(LMM: 18 kDa) isoforms, whereas day 20 EBs expressed
only the LMM isoform (Fig. 1A). Correspondingly, when
hESC cultures were stimulated to differentiate by withdrawal
of exogenous FGF-2 for a shorter period of time (3-5 days),
the nuclear FGF-2 was downregulated. This downregulation
of endogenous FGF-2 was observed exclusively in a loosely
aggregated peripheral hESC subfraction that surrounded the
compact central regions of colonies and was accompanied by
Table 1. Functional clustering of transcription factor regulations associated genes differentially expressed in human ESCs treated with
SU5402 or exogenous FGF-2
Transcription factor network
No. of deregulated
genes in SU5402
Percent in all genes
deregulated in SU5402
No. of deregulated
genes in FGF-2
Percent in all genes
deregulated in FGF-2 p value
TCF4 (b catenin) 80 31.75 27 51.92 .006800282
TF activator protein-4 11 4.37 8 15.38 .007204164
Sox family 13 5.16 8 15.38 .01457261
LXR 1 0.4 3 5.77 .01673897
Activating TF-6 39 15.48 2 3.85 .0247536
Myb 87 34.52 10 19.23 .03386217
LXR direct repeat 4 2 0.79 3 5.77 .03677254
PPAR 106 42.06 30 57.69 .04649849
Pax-3 120 47.62 33 63.46 .04726783
Activating TF-1 5 1.98 4 7.69 .04956299
Meis1B/HOXA9 1 0.4 2 3.85 .07683966
Class I bHLH protein E12 1 0.4 2 3.85 .07683966
RUNX/AML 1 0.4 2 3.85 .07683966
Poly A downstream element 31 12.3 2 3.85 .08737514
bHLH protein DEC 67 26.59 20 38.46 .0934017
PPAR direct repeat 1 209 82.94 48 92.31 .09587495
Note higher number of deregulated genes compared with analysis of molecular and biochemical pathways (Table 2).
Abbreviations: Activating TF-1, Activating transcription factor 1; Activating TF-6, Activating transcription factor 6; bHLH protein DEC,
basic helix-loop-helix protein DEC; Class I bHLH protein E12, Class I basic helix-loop-helix protein E12; FGF-2, ﬁbroblast growth factor 2;
LXR, liver X receptor; LXR direct repeat 4, liver X receptor direct repeat 4; Meis1B/HOXA9, Meis homeobox 1B / homeobox A9; Myb,
myeloblastosis; Pax-3, paired box 3; PPAR, peroxisome proliferator-activated receptor; PPAR direct repeat 1, peroxisome proliferator-
activated receptor direct repeat 1; RUNX/AML, runt related transcription factor / acute myeloid leukemia; Sox family, SRY (sex
determining region Y)-box family; TCF4 (b catenin), transcription factor 4; TF activator protein-4, transcription factor activator protein 4.
Table 2. Functional clustering of molecular or biochemical pathways associated genes differentially expressed in human ESCs treated with
SU5402 or exogenous FGF-2
Molecular or biochemical pathway
No. of deregulated
genes in SU5402
Percent in all genes
deregulated in SU5402
No. of deregulated
genes in FGF-2
Percent in all genes
deregulated in FGF-2 p value
Cell adhesion molecules 2 2.74 3 21.43 .02792073
Adherens junctions 2 2.74 3 21.43 .02792073
MAPK signaling pathway 6 8.22 3 21.43 .1547508
Prostaglandin/leukotriene metabolism 0 0 1 7.14 .1609195
Pyruvate metabolism 0 0 1 7.14 .1609195
Glycolysis/gluconeogenesis 0 0 1 7.14 .1609195
Propanoate metabolism 0 0 1 7.14 .1609195
Focal adhesion 4 5.48 2 14.29 .2464769
Gap junction 1 1.37 1 7.14 .297514
Tight junction 1 1.37 1 7.14 .297514
Regulation of actin cytoskeleton 5 6.85 2 14.29 .3133099
Pyrimidine metabolism 2 2.74 1 7.14 .4132176
ECM–receptor interaction 2 2.74 1 7.14 .4132176
Hematopoietic cell lineage 2 2.74 1 7.14 .4132176
Cysteine metabolism 2 2.74 1 7.14 .4132176
Apoptosis 2 2.74 1 7.14 .4132176
Cell cycle 3 4.11 1 7.14 .5110147
TGFb signaling pathway 3 4.11 1 7.14 .5110147
Wnt signaling pathway 5 6.85 0 0 .5876027
Cytokine–cytokine receptor interaction 5 6.85 0 0 .5876027
Only changes in cell adhesion molecules and adherens junctions were signiﬁcant (p < .05).
Abbreviations: ECM, extracellular matrix; FGF-2, ﬁbroblast growth factor 2; MAPK, mitogen activated protein kinase; TGFb, transforming
growth factor b.
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these peripheral cells appeared to be unaffected (supporting
information Fig. 1). It has been reported that these peripheral
cells, deﬁned as Oct4/IGF1R-negative ﬁbroblast-like cells,
lack clonogenic capacity and upregulate FGFRs that are
almost undetectable in Oct4/IGF1R-positive self-renewing
hESCs [17]. This suggests that an autocrine/paracrine FGF
signaling loop either does not exist or has limited biological
signiﬁcance in a fraction of self-renewing pluripotent hESCs.
In contrast, our previous data showed that inhibition of auto-
crine/paracrine FGF signals causes rapid differentiation, spe-
ciﬁcally in the central regions of colonies [1]. Moreover, here
we show that sorted SSEA3-positive hESCs that possess high
clonogenic capacity [24, 27, 28] express all four FGFRs (sup-
porting information Table 5). To address these contradictions,
we performed a series of FGF-2 binding assays with hESCs
that were maintained in standard conditions with FGF-2 or
cultured without FGF-2 for 3-5 days to induce formation of
peripheral ﬁbroblast-like cells. We observed homogenous
binding of FGF-2 to hESCs cultured under standard condi-
tions (Fig. 1C, top). However, when hESCs were maintained
without exogenous FGF-2 and we observed changes in the
morphology of peripheral cells, these cells showed increased
FGF-2 binding capacity (Fig. 1D, bottom). This suggests that
the controversy in the expression of FGFRs described above
may reﬂect an assay sensitivity issue. Importantly, increased
FGF-2 binding capacity closely correlated with downregula-
tion of endogenous FGF-2, Nanog, and Oct4 and likely repre-
sents a differentiation phenotype (Fig. 1B). Moreover, a corre-
lation between peripheral differentiation induced by
withdrawal of FGF-2 and downregulation of endogenous
FGF-2 expression was observed almost exclusively in low
passage number hESCs (<50; supporting information Fig. 2),
suggesting that FGF-2 requirements change during prolonged
cultivation. These results implicate direct intrinsic FGF-2 sig-
naling in the self-renewal of pluripotent hESCs, although an
indirect role of exogenous FGF-2 in the creation of an hESC
supportive niche by stimulation of hESC-derived peripheral
ﬁbroblast-like cells is also likely.
FGF-2 Knockdown Induces Differentiation of hESCs
To determine whether endogenously synthesized FGF-2 main-
tains the undifferentiated growth of hESCs, we transfected
hESCs with shRNA directed against all molecular isoforms of
FGF-2 and assessed the effects on hESC differentiation. As
determined by immunoblot analysis, this approach reduced the
expression of the 18- and 24-kDa isoforms of FGF-2 by approx-
imately 90% and the 22/22.5-kDa isoforms by 70% (Fig. 2A).
Transfection of hESCs with scrambled shRNA had no effect on
the expression of endogenous FGF-2. In hESCs transfected with
the FGF-2 speciﬁc shRNA, but not in cells transfected with
control shRNA, we consistently observed increased differentia-
tion evidenced by ﬂattened cells in the centers of hESC colo-
nies and peripheral ﬁbroblast-like cells (Fig. 2B). This effect
was visible when hESCs reached higher densities in approxi-
mately 60%–90% of all colonies, suggesting that residual action
of the remaining FGF-2 was sufﬁcient to maintain undifferenti-
ated phenotype in some colonies. Importantly, this effect of
FGF-2 knockdown on the undifferentiated growth of hESCs
was likely not caused by the partial absence of the18-kDa iso-
form of FGF-2, because differentiation was also observed in
hESC cultures supplemented with exogenous 18-kDa FGF-2.
These data reinforce the role of intracrine FGF-2 HMM iso-
forms in maintenance of the undifferentiated growth of hESCs.
FGF-2 Signals in Undifferentiated hESCs Domi-
nantly via FGFR2 and Activates MAPKs and Akt
Kinase
Undifferentiated hESCs synthesize and release LMM FGF-2
and express all four FGFRs (Fig. 1) [1]. Thus, FGF-2 auto-
crine/paracrine signaling can take place. To assess the func-
tion of FGF-2 autocrine/paracrine signaling, we performed
phospho-receptor kinase protein arrays in samples from
Figure 1. Regulated expression of endogenous FGF-2 correlates
with differentiation of hESCs and their binding capacity to exogenous
FGF-2. (A): RT-PCR of FGF-2 gene and immunoblotting of 18-, 22-,
22.5-, and 24-kDa FGF-2 isoforms in undifferentiated and differenti-
ating hESCs. (B): Peripheral differentiation after FGF-2 withdrawal
(arrows) and downregulated nuclear FGF-2, Oct4, and Nanog immu-
noﬂuorescence. (C): Biotinylated FGF-2 (green) binding to undiffer-
entiated hESCs (þFGF-2) or peripherally differentiated hESCs
( FGF-2). Cells are counterstained with 40,6-diamidino-2-phenylin-
dole (blue). Representative results of triplicate experiments. Abbrevia-
tions: EB, embryoid body; FGF-2, ﬁbroblast growth factor-2;
GADPH, glyceraldehyde 3-phosphate dehydrogenase; hESCs, human
ESCs; RT-PCR, reverse transcriptase-polymerase chain reaction.
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days. The dominantly phosphorylated active high afﬁnity FGF
receptor was FGFR2 (Fig. 3A) in exogenous FGF-2-starved
samples, which is a relatively weakly transcribed FGFR in
hESCs (supporting information Table 5) [1]. In agreement
with recently published data [20], the most phosphorylated re-
ceptor tyrosine kinases were IGF1R, insulin receptor, and
members of the EGFR family (EGFR, ErbB2, and ErbB3;
Fig. 3A). Tyrosine phosphorylation of the FGFRs starts im-
mediately after ligand-receptor binding with kinetics that
determine subsequent receptor isoform-speciﬁc activation and
recruitment of intracellular signaling molecules. Thus, we
subjected FGF-2-starved hESCs to 5-, 10-, and 30-minute
stimulation with exogenous FGF-2, which showed that phos-
phorylation of all four FGFRs increased with a maximal
response of FGFR2 10 minutes after the addition of FGF-2
(Fig. 3B). Downstream of FGFRs, activated FRS2/Grb2 com-
plexes recruit SOS or GAB1 and activate the Ras-Raf-MAPK
signaling cascade or the PI3K-Akt cell survival pathway,
respectively. The MAPK and PI3K-Akt pathways can also be
stimulated by activated EGF family receptors, insulin recep-
tors, and IGF1Rs (Fig. 3A). Thus, activation of FGFRs may
be hidden and may produce only weak cumulative effect on
these pathways. To address this question, we examined the
kinetics of FGF-2-mediated phosphorylation of MEKs and
ERKs. Despite the high levels of basal ERK activation, the
phosphorylation of both MEK and ERK signiﬁcantly
increased, with a maximal response 5 minutes after the addi-
tion of FGF-2 (Fig. 3C). Next, we examined the effects of
FGF-2 on a larger panel of MAPKs and the Akt kinase family
using a proteome proﬁler phospho-MAPK array. A 5-minute
treatment with FGF-2 caused activating phosphorylation of
ERK, Akt, and GSK3a/b (Fig. 3D). The phosphorylation of
Akt kinases was 30% higher than controls, whereas ERK1
and 2 increased only 8%–10%. These data suggest that exoge-
nous FGF-2 primarily affects the balance between survival
and apoptosis in hESCs. To test this hypothesis for endoge-
nously produced FGF-2, we inhibited FGF autocrine/paracrine
signaling with SU5402, treated hESCs with human recombi-
nant FGF-2 in parallel, and again analyzed the phosphoryla-
tion level of kinases using phospho-MAPK arrays. Akt1,
Akt2, and pan-Akt phosphorylation levels were lower in cells
exposed to the SU5402 FGFR inhibitor compared with cells
that were starved of exogenous FGF-2 (Fig. 3E), whereas ex-
ogenous FGF-2 had the same activating effect as shown in
Figure 3D. Our results suggest that both exogenous and en-
dogenous FGF-2 regulate Akt kinase signaling.
The 18-kDa Isoform of FGF-2 Regulates hESC
Survival
To examine whether FGF-2 protects hESCs from apoptosis
induced by cellular stress, FGF-2-treated and untreated hESCs
were subjected to ionizing radiation or oxidative stress and
cell death was assessed by lamin B and PARP cleavage, and
terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling assays. Human ESCs grown in the presence of
exogenous LMM FGF-2 were protected from cell death
induced by cellular stress (Fig. 4A, 4B). Also, oxidative stress
consistently increased the expression of LMM FGF-2 by 12
and 24 hours after treatment, suggesting that hESCs synthe-
size FGF-2 to in response to cellular stress (Fig. 4C). In
Figure 2. shRNA-mediated
knockdown of FGF-2 in human
ESCs (hESCs). (A): Immunoblot
of 18-, 22-, 22.5-, and 24-kDa
isoforms of FGF-2. (B): hESC
morphology after FGF-2
depletion; arrows mark differen-
tiation. Undifferentiated mor-
phology of hESCs was not
rescued by addition of 10 ng/ml
FGF-2 (þexogenous FGF-2).
Representative results of dupli-
cate experiments. Abbreviations:
FGF-2, ﬁbroblast growth factor-
2; shRNA, small hairpin RNA.
1852 FGF-2 in hESC Self-Renewal, Survival, and Adhesionaddition, high concentrations of FGF-2 (100 ng/ml) in hESC
cryopreservation medium enhances the post-thaw viability of
hESCs by approximately 15% and signiﬁcantly increases the
number of attached recovered cells (supporting information
Fig. 3A, 3B). Collectively, these results support the hypothe-
sis that LMM FGF-2 supports cell survival.
Exogenous FGF-2 Supports the Cloning Efﬁciency
of hESCs by Enhancing Cellular Adhesion and
Survival
The lower survival rates of hESCs that have been dissociated
into single cell suspensions are likely to be the result of
Figure 3. FGF-2 signaling via FGF re-
ceptor 2, mitogen-activated protein kinases,
and Akt. (A): Phospho-receptor kinases
protein array of FGF-2 starved human
ESCs (hESCs) or (B) after FGF-2 treat-
ment. (C): Immunoblot analysis of MEK
and ERK in time course FGF-2-treated
hESCs. MAPK protein array of hESCs
treated with (D) FGF-2, (E) SU5402, or ve-
hicle (DMSO). Representative results of
more than ﬁve experiments are shown.
Abbreviations: DMSO, dimethylsulfoxide;
EGFR, epidermal growth factor receptor;
ERK, extracellular signal-regulated kinase;
FGF-2, ﬁbroblast growth factor-2; IGF1R,
insulin-like growth factor 1 receptor; MEK,
mitogen-activated protein kinase kinase.
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packed colonies within a tightly regulated stem cell niche. To
test this hypothesis, cells were completely dissociated with
TrypLE reagent, preincubated in suspension with high con-
centrations of FGF-2 (50-100 ng/ml) for 2 hours, and seeded
into feeder cell-coated dishes in medium with the same con-
centrations of FGF-2. After overnight culture, medium with
high concentrations of FGF-2 was changed to a standard me-
dium with 5 ng/ml FGF-2, and cells were cultured for 3-4
days and stained for alkaline phosphatase. As shown in Figure
5A, the number of recovered colonies (cloning efﬁciency)
was higher when hESCs were preincubated and seeded with
FGF-2. However, the cloning efﬁciency with or without FGF-
2 was not signiﬁcantly different when we combined stress
from single cell dissociation with oxidative stress (data not
shown). This raises the possibility that increased cloning efﬁ-
ciency might also reﬂect enhanced cell attachment in cells
that were preincubated with FGF-2. Therefore, we designed a
cell attachment assay where we counted the numbers of and
assessed the viability of nonattached hESCs plated either with
or without FGF-2. The numbers of nonattached cells were
consistently higher, and viability was consistently lower in
hESC cultures that were incubated without exogenous FGF-2
(Fig. 5B). These results show that the stimulatory effect of
FGF-2 on cloning efﬁciency results from a combined
enhancement of cell survival and adhesion.
DISCUSSION
Our experiments have for the ﬁrst time identiﬁed FGF-2 as an
intrinsic regulator of hESC self-renewal and survival. Our
results also suggest that the human recombinant FGF-2 added
to hESC culture media promotes cell adhesion and survival,
but its effect on the maintenance of pluripotency gene expres-
sion is minor. We postulate that exogenous FGF-2 is required
for the undifferentiated growth of hESCs because it promotes
cell adhesion, and thus, growth of compact and regularly
shaped colonies that are less prone to peripheral differentia-
tion. Our observation that exogenous FGF-2 increases replat-
ing efﬁciency of hESCs contradicts an earlier study [29], in
which authors did not observe signiﬁcant improvement in the
replating efﬁciency in the presence of increased concentra-
tions of FGF-2. However, we used TrypLE reagent rather
than trypsin/EDTA, single cell suspensions were immediately
transferred into FGF-2 high culture medium, and cells were
preincubated before seeding. Given that FGF-2 can rescue
Figure 4. Human ESC (hESC) apoptosis and increased expression of FGF-2 in response to cellular stress. (A): Immunoblot of PARP and lamin
B cleavage (3 hours after treatment), and (B) quantitative TUNEL (12 hours after treatment) of hESCs FGF-2 prestarved (6 hours) and incubated
with 10 ng/ml FGF-2 (2 hours) and irradiated (1 Gy) or exposed to H2O2 (50 lM, 1 hour). Control cells were irradiated or exposed to H2O2 in
the absence of exogenous FGF-2. (C): hESCs were treated with 25 lMH 2O2 without exogenous FGF-2 for 12 and 24 hours and immunoblotted
for endogenous FGF-2. Control cells were maintained without H2O2. Representative results of triplicate experiments. Abbreviations: FGF-2, ﬁbro-
blast growth factor-2; IR, irradiated; PARP, poly(ADP-ribose) polymerase; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling.
1854 FGF-2 in hESC Self-Renewal, Survival, and Adhesioncells exposed to cellular stress ([30] and our results) and stim-
ulate cell adhesion, these differences in our experimental
design may have enhanced the survival and adhesion of the
single cell suspensions. Direct effects of exogenous FGF-2 on
hESC adhesion and survival that were uncovered by our study
may be similarly important as the action of exogenous FGF-2
on feeder cells to stimulate TGFb1 and activin A signaling
[15, 16]. In addition, endogenous production of FGF-2 by un-
differentiated hESCs supports an intrinsic pluripotency main-
tenance program. This second pathway raises several ques-
tions. Is the intrinsic FGF-2 pathway a continuation of the
developmentally predetermined self-renewing program of epi-
blast cells or is it an artifact acquired in vitro that ensures the
survival and undifferentiated proliferation of hESCs? Is the
activity of FGF-2 critical for hESC adaptation to in vitro cul-
ture conditions and, to a certain extent, similar to the trans-
forming activity of CUG-initiated HMM isoform of FGF-2 in
other cell types [31]? Do the high and low molecular mass
isoforms of endogenously synthesized FGF-2 have such dis-
tinct functions as described in other cell types [32, 33]? To
partially answer these questions, FGF-2 is known to affect
uterine receptivity [34–36] but was not detected in mamma-
lian blastocyst stage embryos. This suggests that the expres-
sion of FGF-2 in hESCs is an acquired adaptation to in vitro
culture conditions. Similar adaptation to culture conditions
has been observed for chondrocytes isolated from human fetal
growth plate cartilage, which exhibits culture-induced expres-
sion of FGF-2 HMM isoforms [37], and several mouse-
derived cell types cultured from tissue biopsies (P. Krejci,
personal communication).
Whether or not FGF-2 requirements are an in vitro adap-
tation, endogenous FGF-2 clearly plays a critical role in the
undifferentiated growth of hESC in culture. The expression of
HMM FGF-2 has also been shown to enhance proliferation
and survival in suboptimal culture conditions for various cell
types, and it also stimulates cellular transformation and stress/
drug resistance [22]. Our observation that nuclearly localized
HMM FGF-2 is rapidly downregulated when hESCs start to
differentiate at the periphery of tightly packed colonies as a
consequence of withdrawal of exogenous FGF-2 suggests that
LMM FGF-2 participates in the creation of a stem cell niche
by supporting cell adhesion. It also suggests that endoge-
nously produced FGF-2, particularly the HMM isoforms,
decides hESC fate. LMM FGF-2 is a well-established auto-
crine/paracrine regulator of normal ﬁbroblast proliferation
[38] and invasiveness and tumorigenic potential of carcinoma
cells [39]. Similar mechanisms may underlie the ability of
endogenously produced FGF-2 to facilitate the adaptation and
growth of inner cell mass (ICM)-derived cells in vitro. The
intrinsic activities of FGF-2 may also be complemented by
the intrinsic activities of FGF-4, another FGF family member
that was recently suggested to be a regulator of hESC prolif-
eration and differentiation [40].
Our results also showed that FGFR2 is the key signaling
receptor for exogenous FGF-2 in hESCs, even though its
expression is much lower than another FGF-2-cognate recep-
tor, FGFR1. This is consistent with the role of FGFR2 during
mammalian development, where FGFR2 regulates the out-
growth and maintenance of the ICM, basement membrane for-
mation, and epithelial differentiation [41–44]. Simultaneously,
this raises the issue of what the role of dominantly expressed
FGFR1 is in hESCs. FGFR1 may support the attachment of
hESCs by forming nonsignaling complexes with FGF-2 and
the feeder cell-associated extracellular matrix, heparin sulfate
proteoglycans, or cell adhesion molecules as it does in mye-
loid and neural cells [45, 46]. Future studies are underway to
determine whether FGFR1 knockdown affects hESC adhesion,
differentiation, or MAPK activation.
CONCLUSION
In conclusion, FGF-2 plays a complex multilevel role in the
maintenance of hESC pluripotency. Although intracrine FGF-
2 signaling maintains pluripotency gene expression, the exog-
enous recombinant hFGF-2 supplementation of hESC culture
Figure 5. FGF-2 affects the cloning efﬁciency of human ESC
(hESC) single cell suspensions. hESCs were preincubated and seeded
in medium with FGF-2 (100 ng/ml) or without FGF-2. (A): Number
of alkaline phosphatase-positive colonies; numbers represent the mean
of 24 wells of one 24-well plate. (B): Number and viability of nonat-
tached hESCs. Representative results of more than ﬁve experiments
are shown. Abbreviations: FGF-2, ﬁbroblast growth factor-2.
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ripotency by promoting cell adhesion and survival. This com-
plex mechanism of action may also apply to other growth fac-
tor regulators of hESC pluripotency in vitro and represents a
new approach to the research of the maintenance of the undif-
ferentiated growth of hESCs.
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